Mergers & Acquisitions
Does the Medtronic-Covidien mega-merger leave startups in the cold? | MassDevice.com On Call
Allergan urges shareholders to reject Valeant’s $52B hostile takeover bid
Incubator group buys prostate treatment tech from Endo Health
An Israeli medical device incubator said it paid an unspecified amount for the R&D product it co-developed with Endo Health Solutions (NSDQ:ENDP).
Medtronic, Covidien merger: Good or bad for medtech innovation?
Seven questions raised by Medtronic’s $43B Covidien acquisition
Medtronic, Covidien merger: Mass. Gov. Deval Patrick says he’s had no contact with either company
Volcano closes $117M AtheroMed buy
Medtronic-Covidien: What does it mean for medtech? | The week in medtech M&A
Valeant goes hostile in bid for Allergan
Op-ed: Medtronic/Covidien deal good for patients, Minnesota
By: Shaye Mandle, President & CEO, LifeScience Alley
LifeScience Alley, the nation’s largest regional life science industry association, welcomes the news that Medtronic, the world’s leading provider of medical technology products, services and solutions, is acquiring Covidien, a leading global healthcare technology and medical supplies provider.